Thromb Haemost 2006; 95(05): 910-911
DOI: 10.1160/TH06-01-0046
Letters to the Editor
Schattauer GmbH

Correlation of a new point-of-care test with conventional optical aggregometry for the assessment of clopidogrel responsiveness

Nicolas von Beckerath
1   Medizinische Klinik rechts der Isar and Deutsches Herzzentrum, Technische Universität München, Munich, Germany
,
Gisela Pogatsa-Murray
1   Medizinische Klinik rechts der Isar and Deutsches Herzzentrum, Technische Universität München, Munich, Germany
,
Anna Wieczorek
1   Medizinische Klinik rechts der Isar and Deutsches Herzzentrum, Technische Universität München, Munich, Germany
,
Dirk Sibbing
1   Medizinische Klinik rechts der Isar and Deutsches Herzzentrum, Technische Universität München, Munich, Germany
,
Albert Schömig
1   Medizinische Klinik rechts der Isar and Deutsches Herzzentrum, Technische Universität München, Munich, Germany
,
Adnan Kastrati
1   Medizinische Klinik rechts der Isar and Deutsches Herzzentrum, Technische Universität München, Munich, Germany
› Author Affiliations
Further Information

Publication History

Received 23 January 2006

Accepted after revision 05 March 2006

Publication Date:
01 December 2017 (online)

 

 
  • References

  • 1 Gurbel PA, Bliden KP, Hiatt BL. et al. Clopidogrel for coronary stenting. Response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation 2003; 107: 2908-13.
  • 2 Aleil B, Ravanat C, Cazenave JP. et al. Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases. J Thromb Haemost 2005; 03: 85-92.
  • 3 Serebruany VL, Steinhubl SR, Berger PB. et al. Variability in platelet responsiveness to clopidogrel among 544 individuals. J Am Coll Cardiol 2005; 45: 246-51.
  • 4 Accumetrics Inc. Homepage (Accessed January 15, 2006, at) http:\\accumetrics.com
  • 5 von Beckerath N, Taubert D, Pogatsa-Murray G. et al. Absorption, metabolization, and antiplatelet effects of 300-, 600-, and 900-mg loading doses of clopidogrel: results of the ISAR-CHOICE (Intracoronary Stenting and Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect) Trial. Circulation 2005; 112: 2946-50.
  • 6 Steinhubl SR, Kereiakes D. Ultegra rapid platelet function analyzer. Michelson AD. Platelets. Orlando, FL: Academic Press; 2002: 317-23.